fbpx Skip to main content

Findings seen despite the U.S. Preventive Services Task Force revised eligibility criteria

Despite increases in lung cancer screening eligibility, gender, racial, and ethnic screening disparities may still persist, according to a study published online Jan. 12 in JAMA Network Open.

Thomas J. Reese, Pharm.D., Ph.D., from the University of Utah in Salt Lake City, and colleagues used data from the Behavioral Risk Factor Surveillance System (2017 to 2018) to identify adults (aged 50 to 80 years) with a smoking history in 19 states that used the optional lung cancer screening module. Change in eligibility among female, male, Black, Hispanic, and White participants (40,869 individuals) was examined before and after the U.S. Preventive Services Task Force revised eligibility criteria.

The researchers found that the revised criteria increased eligibility for men (29.4 to 38.3 percent), women (25.9 to 36.4 percent), White individuals (31.1 to 40.9 percent), Black individuals (16.3 to 28.8 percent), and Hispanic individuals (10.5 to 18.7 percent). However, the odds of eligibility were lower for women versus men (adjusted odds ratio, 0.88) and for Black (adjusted odds ratio, 0.43) and Hispanic populations (adjusted odds ratio, 0.70) versus Whites.

“These findings suggest that screening disparities may persist among women and racial/ethnic minority populations with the revised guideline,” the authors write.

Abstract/Full Text

You May Also Like::  AI Aids Assessment of Indeterminate Pulmonary Nodules on CT

“Keeping up with the indications and adverse reactions to immune checkpoint inhibitors can be a full-time job. Cutaneous side effects occur in up to 45% of patients treated with ipilimumab and 34% of patients treated with nivolumab and pembrolizumab.” https://bit.ly/3FGtxtd

.@spfnomt: This month’s #DermWorld article “Estate planning 101” is especially important for young physicians to read. The long, all-consuming years between adolescence and physicianhood can become a blur...https://bit.ly/3FxOtCv

That’s a wrap #AAD2023! 5 days of soaking up knowledge from dermatologists on topics such as hidradenitis, melasma, & dietary triggers of common dermatoses.

I LOVED the #womenshealth focused sessions on vulvar dermatoses and pregnancy medication safety.

#dermtwitter
@AADmember

New approach uses microbiome to treat skin disease by repairing the injured microbiome that allowed inflammation to flare up in the first place, rather than reducing the inflammation after the fact. https://bit.ly/3Jt6H9v

Load More